| __timestamp | Alnylam Pharmaceuticals, Inc. | GSK plc |
|---|---|---|
| Wednesday, January 1, 2014 | 50561000 | 15683000000 |
| Thursday, January 1, 2015 | 41097000 | 15070000000 |
| Friday, January 1, 2016 | 47159000 | 18599000000 |
| Sunday, January 1, 2017 | 76545000 | 19844000000 |
| Monday, January 1, 2018 | 73106000 | 20580000000 |
| Tuesday, January 1, 2019 | 194688000 | 21891000000 |
| Wednesday, January 1, 2020 | 414801000 | 22395000000 |
| Friday, January 1, 2021 | 704143000 | 22511000000 |
| Saturday, January 1, 2022 | 868601000 | 19770000000 |
| Sunday, January 1, 2023 | 1517886000 | 21763000000 |
| Monday, January 1, 2024 | 1924873000 |
In pursuit of knowledge
In the competitive world of pharmaceuticals, gross profit is a key indicator of a company's financial health and market position. Over the past decade, GSK plc has consistently outperformed Alnylam Pharmaceuticals, Inc. in terms of gross profit. From 2014 to 2023, GSK's gross profit has remained robust, averaging around $20 billion annually, with a peak in 2021. In contrast, Alnylam's gross profit, while showing impressive growth, started from a modest base and reached approximately $1.5 billion in 2023. This represents a significant increase of over 2,900% from its 2014 figures. Despite Alnylam's rapid growth, GSK's established market presence and consistent performance highlight the challenges new entrants face in catching up with industry giants. As the pharmaceutical landscape evolves, it will be intriguing to see how these dynamics shift in the coming years.
Gross Profit Comparison: Amgen Inc. and GSK plc Trends
Gross Profit Comparison: Sanofi and GSK plc Trends
GSK plc or Alnylam Pharmaceuticals, Inc.: Who Leads in Yearly Revenue?
Who Generates Higher Gross Profit? GSK plc or Ascendis Pharma A/S
Gross Profit Analysis: Comparing GSK plc and Bausch Health Companies Inc.
Alnylam Pharmaceuticals, Inc. and Dr. Reddy's Laboratories Limited: A Detailed Gross Profit Analysis
Gross Profit Comparison: Alnylam Pharmaceuticals, Inc. and BioMarin Pharmaceutical Inc. Trends
Gross Profit Analysis: Comparing Alnylam Pharmaceuticals, Inc. and Alkermes plc
Gross Profit Comparison: Alnylam Pharmaceuticals, Inc. and Veracyte, Inc. Trends
Gross Profit Analysis: Comparing Alnylam Pharmaceuticals, Inc. and Vericel Corporation
Who Generates Higher Gross Profit? Alnylam Pharmaceuticals, Inc. or Ligand Pharmaceuticals Incorporated
Gross Profit Trends Compared: Alnylam Pharmaceuticals, Inc. vs Travere Therapeutics, Inc.